Clinical Trials
Sponsor:
Sponsor Study ID:
Study Title:
A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers
NCT Number:
NCT04597359
Phase:
II
Protocol Type:
Prevention
Age Group:
Adults
Disease Sites:
Prostate
Study Objectives:
This phase II trial studies how well green tea catechins work in preventing progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance. Green tea catechins may stabilize prostate cancer and lower the chance of prostate growing.
Study Documents
(MUSC NetID required for document access)